Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carraguard (PC-515) in Preventing STI/HIV Transmission
NCT00213018Phase 2Completed
- Sponsor
- Population Council
- Start
- Oct 1999
- Modality
- Polymer-based Nanoparticles
- Countries
- 1
01
Overview
A Phase 2 trial of Carraguard in human immunodeficiency virus infection (HIV), Chlamydia trachomatis infection (CT), gonorrhea, trichomoniasis (trich), syphilis, sponsored by Population Council. Started Oct 1999; status: completed.
02
Drugs
Carraguard
03
Conditions
human immunodeficiency virus infection (HIV)Chlamydia trachomatis infection (CT)gonorrheatrichomoniasis (trich)syphilis
Beyond the preview
Go deeper on NCT00213018.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00213018.